Introduction of Somatrogon in Pediatric Growth Hormone Deficiency: Real-World Insights From a National Survey of Pediatric Endocrinologists
This survey revealed heterogenous long-acting growth hormone prescribing behaviors among pediatric endocrinologists during the introductory period of its availability. The findings call for continued search for real-world evidence and refined clinical guidelines to promote effective and safe integration of this promising therapy into clinical practice.
Authors
- Anat Segev Becker
- Asaf Oren (ORCID: https://orcid.org/0000-0002-2790-8866)
- Ravit Regev (ORCID: https://orcid.org/0000-0002-0846-733X)
- Ori Eyal (ORCID: https://orcid.org/0000-0002-8030-1588)
- Avivit Brener (ORCID: https://orcid.org/0000-0002-2742-8264)
- Yael Lebenthal (ORCID: https://orcid.org/0000-0001-5963-0574)
- Marianna Rachmiel (ORCID: https://orcid.org/0000-0002-0852-0831)
- Ariel Tenenbaum (ORCID: https://orcid.org/0000-0002-4552-6909)
- Kineret Mazor‐Aronovitch (ORCID: https://orcid.org/0000-0001-6153-598X)
- Liat Perl (ORCID: https://orcid.org/0000-0002-8207-1130)
- Eyal Cohen‐Sela (ORCID: https://orcid.org/0009-0008-0083-9443)
Institutions
- Tel Aviv Sourasky Medical Center (IL)
- Schneider Children's Medical Center (IL)
- Assaf Harofeh Medical Center (IL)
- Edmond and Lily Safra Children's Hospital (IL)
Publication Details
- Journal
- Endocrine Practice
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.eprac.2025.11.008
- Citations
- 1
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.29